Please assess the completion status of the following clinical trial:

Trial Title: A Study Evaluating the Safety and Effectiveness of the PulseRider® Aneurysm Neck Reconstruction Device Used in Conjunction With Endovascular Coil Embolization in the Treatment of Wide-Neck Bifurcation Intracranial Aneurysm

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Subject with wide neck intracranial aneurysm located at a bifurcation~2. The subject is between 18 and 80 years of age the time of consent~3. Informed consent is obtained and the subject signs the IRB approved consent prior to beginning any study procedures~4. In the opinion of the treating physician, placement of the PulseRider® device is technically feasible and clinically indicated~Exclusion Criteria:~1. Unstable neurological deficit (condition worsening within the last 90 days)~2. Subarachnoid Hemorrhage (SAH) within the last 60 days~3. Irreversible bleeding disorder~4. Patient has another intracranial aneurysm that in the Investigator's opinion, may require treatment within the 1 year follow up period~5. A history of contrast allergy that cannot be medically controlled~6. Known allergy to nickel~7. Relative contraindication to angiography~8. Woman of child-bearing potential who cannot provide a negative pregnancy test~9. Current involvement in a study for another investigational product~10. Patient and / or family considering a move from this geographical location at the time of consent~11. Categorized as a vulnerable population and require special treatment with respect to safeguards of well-being (e.g. cognitively impaired, veteran, prisoner, etc.)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Treatment Group (Type: EXPERIMENTAL): PulseRider® Aneurysm Neck Reconstruction in conjunction with coil embolization for unruptured wide-neck intracranial aneurysms.

Based on this trial design, predict the completion outcome and termination type (if applicable).